Publications

Publications

Filter Results: (285) Arrow Down

Show Results For

← Page 3 of 285 Results →

    Andy Wu

    Andy Wu is the Arjun and Minoo Melwani Family Associate Professor of Business Administration in the Strategy Unit at Harvard Business School, where he teaches in the MBA and Executive Education programs. He researches, teaches, and advises managers... View Details

    Keywords: software; e-commerce industry; venture capital industry; biotechnology; video games
    • 26 Nov 2013
    • First Look

    First Look: November 26

      Publications August 2013 Journal of Corporate Finance Golden Parachutes and the Wealth of Shareholders By: Bebchuk, Lucian A., Alma Cohen, and Charles C.Y. Wang Abstract—Golden parachutes (GPs) have attracted substantial attention from... View Details
    Keywords: Sean Silverthorne
    • Article

    Big Names or Big Ideas: Do Peer-Review Panels Select the Best Science Proposals?

    By: Danielle Li and Leila Agha
    This paper examines the success of peer-review panels in predicting the future quality of proposed research. We construct new data to track publication, citation, and patenting outcomes associated with more than 130,000 research project (R01) grants funded by the U.S.... View Details
    Keywords: Patents; Research; Entrepreneurship; Forecasting and Prediction; Innovation and Invention; Business and Government Relations; United States
    Related
    • 04 Apr 2016
    • HBS Seminar

    Ariel Stern, Harvard Business School

    • August 2001
    • Case

    Pharmaceutical Industry and the AIDS Crisis in Developing Countries, The

    Explores the controversy over the pricing of AIDS drugs in poor countries. This issue has received wide publicity due to two events: 1) a court case in South Africa that seeks to force drug companies to license their patents and 2) the announcement by the Indian... View Details
    Keywords: Competition; Developing Countries and Economies; Business and Government Relations; Pharmaceutical Industry; South Africa; India
    Related
    • 26 Feb 2007
    • Research & Ideas

    The Power of the Noncompete Clause

    passed, often twelve to twenty-four months. Such a clause, for instance, sparked a public legal battle two years ago when Google hired away a top Microsoft executive, Kai-Fu Lee. But disputes and tensions over noncompetes are not isolated... View Details
    Keywords: by Martha Lagace

      Josh Lerner

      Josh Lerner graduated from Yale College with a special divisional major. He worked for several years on issues concerning technological innovation and public policy at the Brookings Institution, for a public-private task force in Chicago, and on... View Details

      Keywords: biotechnology; high technology; venture capital industry
      • March 2020
      • Article

      Do Managers Matter? A Natural Experiment from 42 R&D Labs in India

      By: Prithwiraj Choudhury, Tarun Khanna and Christos A. Makridis
      We exploit plausibly exogenous variation in the staggered entry of new managers into India’s 42 public R&D labs between 1994 and 2006 to study how alignment between the CEO and middle-level managers affect research productivity. We show that the introduction of new lab... View Details
      Keywords: Incentives; Innovation; Productivity; Management; Alignment; Research and Development; Innovation and Invention; Performance Productivity; India
      Related
      • 05 Sep 2006
      • First Look

      First Look: September 5, 2006

      believing concentration is increasing even when it isn't, and to discuss possible reasons. What Is the Impact of Software Patent Shifts? Evidence from Lotus v. Borland Authors:Josh Lerner and Feng Zhu Periodical:International Journal of... View Details
      Keywords: Sean Silverthorne
      • 2021
      • Working Paper

      Technology Differentiation and Firm Performance

      By: Sam Arts, Bruno Cassiman and Jianan Hou
      Prior work has extensively studied how investing in R&D and building a technology portfolio relate to superior firm performance. However, the value of a firm’s technology portfolio should also be driven by the degree to which it is more unique and technologically... View Details
      Keywords: Technology Portfolio; Differentiation; Competitiveness; Organizations; Technology; Performance; United States
      Related
      • January 2011
      • Supplement

      Matrix Capital Management (B)

      By: Malcolm P. Baker and David Lane
      Ben Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale... View Details
      Keywords: Public Ownership; Cash Flow; Management Analysis, Tools, and Techniques; Investment Funds; Financial Strategy; Valuation; Partners and Partnerships; Markets; Performance Efficiency; Patents; Stock Shares; Decisions; Financial Services Industry
      Related
      • 04 Dec 2018
      • First Look

      New Research and Ideas, December 4, 2018

      public firms during this period were only 41% of net income. And, in fact, during this decade investment increased substantially while cash balances ballooned. In short, S&P 500 shareholder-payout figures cannot provide much basis for... View Details
      Keywords: Dina Gerdeman
      • January 2011
      • Supplement

      Matrix Capital Management (C)

      By: Malcolm P. Baker and David Lane
      Ben Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale... View Details
      Keywords: Public Ownership; Cash Flow; Management Analysis, Tools, and Techniques; Investment Funds; Financial Strategy; Valuation; Partners and Partnerships; Markets; Performance Efficiency; Patents; Stock Shares; Decisions; Financial Services Industry
      Related

        Estimating Spillovers from Publicly Funded R&D: Evidence from the US Department of Energy

        The spillovers from public R&D grants are large and reach far across geographic and technological space, and focusing only on firms that directly receive grants causes... View Details

        • 25 Jul 2023
        • Research & Ideas

        Could a Business Model Help Big Pharma Save Lives and Profit?

        cross-sector and cross-border partnerships needed to execute the model. Adding new information about how pharmaceutical companies handle global public health challenges. Jessica Martinez, a former Big Pharma executive who joined the Bill... View Details
        Keywords: by Esther Schrader; Pharmaceutical; Health
        • 14 Feb 2013
        • Working Paper Summaries

        Fostering Translational Research: Using Public-Private Partnerships to Improve Firm Survival, Employment Growth, and Innovative Performance

        Keywords: by Sen Chai & Willy C. Shih; Education
        • March 1996
        • Case

        Erox Corporation: Leverage Marketing

        Erox Corp. is a biotechnology start-up that creates products containing synthetic human pheromones. It was founded in 1989, went public in 1993, and brought in a turnaround team in 1994. Sales ramped from $110,000 in 1993 to over $1 million in 1994, with prospects for... View Details
        Keywords: Marketing Communications; Entrepreneurship; Biotechnology Industry
        Related
        • 27 Aug 2013
        • First Look

        First Look: August 27

          Publications August 2013 Journal of Financial Economics The Performance of Corporate Alliances: Evidence from Oil and Gas Drilling in the Gulf of Mexico By: Beshears, John Abstract—I use data on oil and gas drilling in the Gulf of... View Details
        Keywords: Sean Silverthorne
        • 20 May 2014
        • First Look

        First Look: May 20

          Publications August 2013 Journal of the European Economic Association Sovereigns, Upstream Capital Flows and Global Imbalances By: Alfaro, Laura, Sebnem Kalemli-Ozcan, and Vadym Volosovych Abstract—We construct measures of net private... View Details
        Keywords: Sean Silverthorne
        • 2014
        • Working Paper

        Bridging Science and Technology Through Academic-Industry Partnerships

        By: Sen Chai and Willy C. Shih
        Scientific research and its translation into commercialized technology is a driver of wealth creation and economic growth. Partnerships to foster the translational processes from public research organizations, such as universities and hospitals, to private firms are a... View Details
        Keywords: Innovation; Firm Performance; Public-private Partnership Funding; Translational Research; Small And Medium Enterprises; Partners and Partnerships; Public Sector; Private Sector; Performance; Science-Based Business; Innovation and Invention
        Related